Poster Poster Program Radiopharmaceuticals, Theranostics, and Nuclear Medicine

Analysis of Y-90 Dose Delivery Uncertainties

Abstract
Purpose

In the process to calculate the delivered Y-90 (Yttrium-90) dosage, there is measurement uncertainty associated with each step. All these uncertainties can be calculated with the knowledge of the dose calibrator and survey meter accuracy and the estimated operator’s reading uncertainties. The purpose of this project is to analyze the contribution of all the uncertainty sources to calculate the final delivery accuracy.

Methods

The first step in Y90 delivery is to assay the activity of the prescribed unit dose. The assay uncertainty is determined by the dose calibrator accuracy. The second step is to measure the exposure rate of the unit dose before delivery. The third step is to measure the exposure rate of the waste after delivery. The exposure rate ratio of the waste to the unit dose and the assayed activity are used to calculated the final dose delivered. We derived the formula to calculate the uncertainties at each step. The calculation was applied to analyze the uncertainties of the Y-90 delivery for our institute’s most recent 100 cases.

Results

The assay and the exposure rate ratio percentage uncertainties were proved to be independent to each other. There were 17 cases with initial exposure rate below 1mR/h. They all had exposure rate ratio uncertainties equal or above 5% (the highest being 14%). All other cases with initial exposure rate readings above 1mR/h had uncertainties below 5%. 43 high dose cases had uncertainties below 1%. The final dose percentage uncertainty would be the sum of the above percentage and the dose calibrator accuracy.

Conclusion

For a successful delivery, the waste exposure rate was usually close to the background. The exposure rate ratio would be higher for low dose cases whose initial exposure rate was low. This was the major reason for high delivery uncertainties for low dose cases.

People

Related

Similar sessions

Poster Poster Program
Jul 19 · 07:00
Adverse Events in Targeted Radionuclide Therapy

Radiopharmaceutical therapy (RPT) plays an important role in the management of oncology patients, particularly those with thyroid cancer, prostate cancer, and neuroendocrine tumor. The use of radionuclide therapy has expanded rap...

Harrison L. Agordzo
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Development of a Web-Based Theranostic Workflow Management Tool

To develop a Web-Based Theranostic Workflow Management Tool (TWMT) to efficiently manage Theranostic program in the department of radiation oncology (RadOnc).

Ling Zhuang, PhD
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested
Poster Poster Program
Jul 19 · 07:00
Epidseg-Net:the Multi-Modal Fusion Framework Based on Drr Guidance In Radiotherapy Is Used for Precise Segmentation of Epid Lung Targets

The proposed multimodal segmentation framework, named EPIDSeg-Net, comprises an encoder, a multi-scale feature layer, and a decoder. The encoder utilizes a dual-branch architecture: a CNN branch for extracting local texture featu...

Huang Qian Qianjia, M.Eng
Radiopharmaceuticals, Theranostics, and Nuclear Medicine 0 people interested